Dulaglutide
Showing 1 - 25 of 111
Diabetes, Type 2 Trial (Dulaglutide)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Dulaglutide
- (no location specified)
Dec 20, 2022
Healthy Volunteers, Diabetes, Type 2, Overweight Trial in Groningen (Semaglutide, Dulaglutide)
Completed
- Healthy Volunteers
- +3 more
- Semaglutide
- Dulaglutide
-
Groningen, NetherlandsNovo Nordisk Investigational Site
Nov 4, 2022
Metabolic-associated Fatty Liver Disease, Type 2 Diabetes Trial (Empagliflozin, Dulaglutide, Empagliflozin and Dulaglutide)
Not yet recruiting
- Metabolic-associated Fatty Liver Disease
- Type 2 Diabetes
- Empagliflozin
- +2 more
- (no location specified)
Oct 1, 2022
T2DM (Type 2 Diabetes) Trial in Shanghai (Ecnoglutide high dosage, Ecnoglutide low dosage, Dulaglutide)
Not yet recruiting
- T2DM (Type 2 Diabetes Mellitus)
- Ecnoglutide high dosage
- +3 more
-
Shanghai, Shanghai, ChinaZHONGSHAN Hospital
Dec 25, 2022
Novel Antidiabetic Medications and Their Effect on Liver
Completed
- Non-Alcoholic Fatty Liver Disease
- Liver Steatosis
- Empagliflozin
- +2 more
-
Athens, Attiki, Greece"Hippocration" General Hospital of Athens
Jul 13, 2023
Type 2 Diabetes Trial in Beijing (dulaglutide, IBI362)
Not yet recruiting
- Type 2 Diabetes
- dulaglutide
- IBI362
-
Beijing, ChinaChina-Japan Friendship Hospital
Nov 1, 2022
Type 2 Diabetes, Glucose, High Blood Trial in Cheonju (IGlarLixi, Dulaglutide)
Active, not recruiting
- Type 2 Diabetes Mellitus
- Glucose, High Blood
- IGlarLixi
- Dulaglutide
-
Cheonju, Chungcheongbuk-do, Korea, Republic ofChungbuk National University Hospital
Jul 19, 2022
Dulaglutide on Glycemic Variability in Type 2 Diabetes
Completed
- Type 2 Diabetes
- Dulaglutide 1.5 MG/ML
-
Shanghai, China180 Fenglin Road
Mar 30, 2022
Type 2 Diabetes Treated With Insulin, Obesity, Adolescent Obesity Trial in Lahore (Dulaglutide, Liraglutide)
Completed
- Type 2 Diabetes Treated With Insulin
- +2 more
- Dulaglutide
- Liraglutide
-
Lahore, Punjab, PakistanZainab Khan
Mar 11, 2022
Type 2 Diabetes Trial in Zibo (14028 injection, dulaglutide injection)
Recruiting
- Type 2 Diabetes
- 14028 injection
- dulaglutide injection
-
Zibo, Shandong, ChinaPKUCare Luzhong Hospital
Jul 12, 2022
Polycystic Ovary Syndrome Trial in Shanghai (GLP-1 RAs, calorie restricted diet)
Completed
- Polycystic Ovary Syndrome
- GLP-1 RAs
- calorie restricted diet
-
Shanghai, Shanghai, ChinaShanghai Tenth People' Hospital
Aug 2, 2022
Type 2 Diabetes Trial in Beijing (IBI362, , Dulaglutide)
Active, not recruiting
- Type 2 Diabetes
- IBI362
- +2 more
-
Beijing, Beijing, ChinaChina Japan Friendship Hospital
Jul 15, 2022
Type 2 Diabetes Trial in Shijia Zhuang (TG103,Q2W, TG103,QW, Placebo,Q2W)
Not yet recruiting
- Type 2 Diabetes Mellitus
- TG103,Q2W
- +4 more
-
Shijia Zhuang, Hebei, ChinaGao Huanhuan
Jun 9, 2022
Hyperglycemia Stress Trial in Atlanta (Dulaglutide, Placebo, Continuous glucose monitor (CGM), blinded)
Recruiting
- Hyperglycemia Stress
- Dulaglutide
- +2 more
-
Atlanta, Georgia
- +1 more
Dec 6, 2022
Cystic Fibrosis, Pancreatic Insufficiency, Abnormal Glucose Tolerance Trial in Philadelphia (Dulaglutide 0.75Mg/0.5Ml Inj Pen)
Recruiting
- Cystic Fibrosis
- +3 more
- Dulaglutide 0.75Mg/0.5Ml Inj Pen
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 11, 2023
Type 2 Diabetes Trial in Beijing, Shijiazhuang (HEC88473, Placebo, Dulaglutide)
Recruiting
- Type 2 Diabetes
- HEC88473, Placebo, Dulaglutide
-
Beijing, Beijing, China
- +1 more
Nov 20, 2023
Sexual Functioning Trial in Basel (Dulaglutide, Placebo)
Recruiting
- Sexual Functioning
- Dulaglutide
- Placebo
-
Basel, SwitzerlandUniversity Hospital Basel, Endocrinology, Diabetes and Metabolis
Mar 3, 2022
Diabetes, Diabetic Kidney Disease Trial in Sha Tin (Dulaglutide, Insulin Degludec, Continuous glucose monitor)
Recruiting
- Diabetes Mellitus
- Diabetic Kidney Disease
- Dulaglutide
- +2 more
-
Sha Tin, Hong KongPrince of Wales Hospital
Nov 8, 2022
Diabetes, Type 2, Overweight or Obesity Trial in China (Beinaglutide, Dulaglutide)
Recruiting
- Diabetes Mellitus, Type 2
- Overweight or Obesity
- Beinaglutide
- Dulaglutide
-
Guangzhou, Guangdong, China
- +3 more
Aug 25, 2021
Diabetes, Type 1, Endothelial Dysfunction Trial in Charlottesville (Dulaglutide, Placebo, exercise training)
Not yet recruiting
- Diabetes Mellitus, Type 1
- Endothelial Dysfunction
- Dulaglutide
- +2 more
-
Charlottesville, VirginiaUniversity of Virginia
Jul 25, 2022
Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial in Japan (Dulaglutide, Biguanide (BG), Sulfonylurea (SU))
Active, not recruiting
- Diabetes Mellitus
- +6 more
- Dulaglutide
- +6 more
-
Nagoya-shi, Aichi, Japan
- +43 more
Jan 16, 2023
Chronic Kidney Diseases Trial in Nashville (dulaglutide injection)
Recruiting
- Chronic Kidney Diseases
- dulaglutide injection
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 20, 2022